142 related articles for article (PubMed ID: 34453120)
1. Steatosis, inflammasome upregulation, and fibrosis are attenuated in miR-155 deficient mice in a high fat-cholesterol-sugar diet-induced model of NASH.
Bala S; Ganz M; Babuta M; Zhuang Y; Csak T; Calenda CD; Szabo G
Lab Invest; 2021 Dec; 101(12):1540-1549. PubMed ID: 34453120
[TBL] [Abstract][Full Text] [Related]
2. Hepatic Deficiency of Augmenter of Liver Regeneration Predisposes to Nonalcoholic Steatohepatitis and Fibrosis.
Kumar S; Verma AK; Rani R; Sharma A; Wang J; Shah SA; Behari J; Salazar Gonzalez R; Kohli R; Gandhi CR
Hepatology; 2020 Nov; 72(5):1586-1604. PubMed ID: 32031683
[TBL] [Abstract][Full Text] [Related]
3. Progression of non-alcoholic steatosis to steatohepatitis and fibrosis parallels cumulative accumulation of danger signals that promote inflammation and liver tumors in a high fat-cholesterol-sugar diet model in mice.
Ganz M; Bukong TN; Csak T; Saha B; Park JK; Ambade A; Kodys K; Szabo G
J Transl Med; 2015 Jun; 13():193. PubMed ID: 26077675
[TBL] [Abstract][Full Text] [Related]
4. NLRP3 inflammasome activation is required for fibrosis development in NAFLD.
Wree A; McGeough MD; Peña CA; Schlattjan M; Li H; Inzaugarat ME; Messer K; Canbay A; Hoffman HM; Feldstein AE
J Mol Med (Berl); 2014 Oct; 92(10):1069-82. PubMed ID: 24861026
[TBL] [Abstract][Full Text] [Related]
5. Protective role of cGAS in NASH is related to the maintenance of intestinal homeostasis.
de Carvalho Ribeiro M; Cho Y; Mehta J; Wang X; Babuta M; Copeland C; Hussein H; Catalano D; Wang Y; Szabo G
Liver Int; 2023 Sep; 43(9):1937-1949. PubMed ID: 37222257
[TBL] [Abstract][Full Text] [Related]
6. Deficiency of the Purinergic Receptor 2X
Blasetti Fantauzzi C; Menini S; Iacobini C; Rossi C; Santini E; Solini A; Pugliese G
Oxid Med Cell Longev; 2017; 2017():8962458. PubMed ID: 29270247
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of NLRP3 inflammasome by thioredoxin-interacting protein in mouse Kupffer cells as a regulatory mechanism for non-alcoholic fatty liver disease development.
He K; Zhu X; Liu Y; Miao C; Wang T; Li P; Zhao L; Chen Y; Gong J; Cai C; Li J; Li S; Ruan XZ; Gong J
Oncotarget; 2017 Jun; 8(23):37657-37672. PubMed ID: 28499273
[TBL] [Abstract][Full Text] [Related]
8. NLRP3 deficiency did not attenuate NASH development under high fat calorie diet plus high fructose and glucose in drinking water.
Zhu LY; Liu C; Li ZR; Niu C; Wu J
Lab Invest; 2021 May; 101(5):588-599. PubMed ID: 33526807
[TBL] [Abstract][Full Text] [Related]
9. Deletion of Thioredoxin-interacting protein ameliorates high fat diet-induced non-alcoholic steatohepatitis through modulation of Toll-like receptor 2-NLRP3-inflammasome axis: Histological and immunohistochemical study.
Mohamed IN; Sarhan NR; Eladl MA; El-Remessy AB; El-Sherbiny M
Acta Histochem; 2018 Apr; 120(3):242-254. PubMed ID: 29482933
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-155 Deficiency Attenuates Liver Steatosis and Fibrosis without Reducing Inflammation in a Mouse Model of Steatohepatitis.
Csak T; Bala S; Lippai D; Kodys K; Catalano D; Iracheta-Vellve A; Szabo G
PLoS One; 2015; 10(6):e0129251. PubMed ID: 26042593
[TBL] [Abstract][Full Text] [Related]
11. Astaxanthin inhibits inflammation and fibrosis in the liver and adipose tissue of mouse models of diet-induced obesity and nonalcoholic steatohepatitis.
Kim B; Farruggia C; Ku CS; Pham TX; Yang Y; Bae M; Wegner CJ; Farrell NJ; Harness E; Park YK; Koo SI; Lee JY
J Nutr Biochem; 2017 May; 43():27-35. PubMed ID: 28193580
[TBL] [Abstract][Full Text] [Related]
12. Bax inhibitor-1 protects from nonalcoholic steatohepatitis by limiting inositol-requiring enzyme 1 alpha signaling in mice.
Lebeaupin C; Vallée D; Rousseau D; Patouraux S; Bonnafous S; Adam G; Luciano F; Luci C; Anty R; Iannelli A; Marchetti S; Kroemer G; Lacas-Gervais S; Tran A; Gual P; Bailly-Maitre B
Hepatology; 2018 Aug; 68(2):515-532. PubMed ID: 29457838
[TBL] [Abstract][Full Text] [Related]
13. Benzyl isothiocyanate ameliorates high-fat/cholesterol/cholic acid diet-induced nonalcoholic steatohepatitis through inhibiting cholesterol crystal-activated NLRP3 inflammasome in Kupffer cells.
Chen HW; Yen CC; Kuo LL; Lo CW; Huang CS; Chen CC; Lii CK
Toxicol Appl Pharmacol; 2020 Apr; 393():114941. PubMed ID: 32126212
[TBL] [Abstract][Full Text] [Related]
14. Both bone marrow-derived and non-bone marrow-derived cells contribute to AIM2 and NLRP3 inflammasome activation in a MyD88-dependent manner in dietary steatohepatitis.
Csak T; Pillai A; Ganz M; Lippai D; Petrasek J; Park JK; Kodys K; Dolganiuc A; Kurt-Jones EA; Szabo G
Liver Int; 2014 Oct; 34(9):1402-13. PubMed ID: 24650018
[TBL] [Abstract][Full Text] [Related]
15. Ch25h and 25-HC prevent liver steatosis through regulation of cholesterol metabolism and inflammation.
Wang Y; Zhang J; Chen J; Wang D; Yu Y; Qiu P; Wang Q; Zhao W; Li Z; Lei T
Acta Biochim Biophys Sin (Shanghai); 2022 Apr; 54(4):504-513. PubMed ID: 35462473
[TBL] [Abstract][Full Text] [Related]
16. Exercise suppresses NLRP3 inflammasome activation in mice with diet-induced NASH: a plausible role of adropin.
Yang W; Liu L; Wei Y; Fang C; Liu S; Zhou F; Li Y; Zhao G; Guo Z; Luo Y; Li L
Lab Invest; 2021 Mar; 101(3):369-380. PubMed ID: 33268842
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA expression analysis in high fat diet-induced NAFLD-NASH-HCC progression: study on C57BL/6J mice.
Tessitore A; Cicciarelli G; Del Vecchio F; Gaggiano A; Verzella D; Fischietti M; Mastroiaco V; Vetuschi A; Sferra R; Barnabei R; Capece D; Zazzeroni F; Alesse E
BMC Cancer; 2016 Jan; 16():3. PubMed ID: 26728044
[TBL] [Abstract][Full Text] [Related]
18. Pemafibrate suppresses NLRP3 inflammasome activation in the liver and heart in a novel mouse model of steatohepatitis-related cardiomyopathy.
Kanno K; Koseki M; Chang J; Saga A; Inui H; Okada T; Tanaka K; Asaji M; Zhu Y; Ide S; Saito S; Higo T; Okuzaki D; Ohama T; Nishida M; Kamada Y; Ono M; Saibara T; Yamashita S; Sakata Y
Sci Rep; 2022 Feb; 12(1):2996. PubMed ID: 35194060
[TBL] [Abstract][Full Text] [Related]
19. CREBH knockout accelerates hepatic fibrosis in mouse models of diet-induced nonalcoholic fatty liver disease.
Li G; Zhang J; Jiang Q; Liu B; Xu K
Life Sci; 2020 Aug; 254():117795. PubMed ID: 32417373
[TBL] [Abstract][Full Text] [Related]
20. Carnosic acid protects mice from high-fat diet-induced NAFLD by regulating MARCKS.
Song HM; Li X; Liu YY; Lu WP; Cui ZH; Zhou L; Yao D; Zhang HM
Int J Mol Med; 2018 Jul; 42(1):193-207. PubMed ID: 29620148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]